Vasta Platform announced the beginning of a transition period of its CFO. From today until September 15, CFO Bruno Giardino will transfer his activities to Cesar Augusto Silva, after which Giardino will be dedicated to personal projects. After September, 15, Silva will serve as Vasta's new CFO, and Mario Ghio Junior, Vasta's CEO, will assume the responsibilities of Investor Relations Officer as well. Silva is an economist and accountant with an MBA in business administration, and has more than 25 years' experience in financial management and controllership. Silva has been working at the Cogna Group as Controllership Director since 2016, having actively participated in Vasta's IPO process with Nasdaq.

PureCycle Technologies announced a corporate update and financial results for Q2. The operational start-up of PureCycle's flagship facility in Ironton remains on track. The Augusta multi-line purification facility build-out is underway, with startup now expected to be in 1Q24. Project debt financing is expected to be completed by Q4. Upon the anticipated closing of this transaction, the company expects to have sufficient capital to fund Augusta's first two purification lines and three East Coast PreP facilities. During Q2, the company's engineering, procurement, and construction activities at its first multi-line purification facility in Augusta continued to make progress. The company received a FDA prenotification letter confirming that the company will receive an agency opinion letter for the use of food-grade post-industrial recycled materials for all food types under Conditions of Use A-H, and a Letter of No Objection for all food types under Conditions of Use E-G for food-grade post-consumer recycled feedstock. PureCycle has continued to advance the feedstock procurement pipeline, with approximately 329 million pounds of polypropylene under Letter of Intent, to fully supply the first two lines of PureCycle's Augusta's purification facility. As of June 30, the company had total liquidity of $516.4M including $349.8M of cash, cash equivalents and debt securities available for sale and $166.6M in restricted cash. PureCycle had $249.6M in debt and accrued interest, less $16.6M of discount and issuance costs as of June 30. PureCycle's Ironton flagship purification facility's budget estimate is approximately $300M, which was primarily funded through bond financing.

The ResMed board declared a quarterly cash dividend of 44c per share. The dividend will have a record date of August 18, payable on September 22.